Schott, a provider of pharmaceutical packaging, plans to double capacity at its syringe competence center in St. Gallen, Switzerland.

The company reports that additional production at its St. Gallen site began in June. Further capacity is being installed and will be in operation next year. The company says the additional capacity is in response to increased demand for prefilled polymer syringes.

The new production capacity will integrate into Schott’s existing setup and advanced technologies. In this facility design, syringes are manufactured in cleanrooms with an automated process starting from injection molding to the final packaging in nest and tub. Afterwards, the syringes are sterilized and ready for aseptic filling operations.

Source: Schott